Search

Your search keyword '"Substantia nigra compacta"' showing total 22 results

Search Constraints

Start Over You searched for: Descriptor "Substantia nigra compacta" Remove constraint Descriptor: "Substantia nigra compacta" Language english Remove constraint Language: english
22 results on '"Substantia nigra compacta"'

Search Results

1. LRRK2‐G2019S mice display alterations in glutamatergic synaptic transmission in midbrain dopamine neurons.

2. Spatial RNA Sequencing Identifies Robust Markers of Vulnerable and Resistant Human Midbrain Dopamine Neurons and Their Expression in Parkinson’s Disease

3. Spatial RNA Sequencing Identifies Robust Markers of Vulnerable and Resistant Human Midbrain Dopamine Neurons and Their Expression in Parkinson's Disease.

4. SINAPTIC PLASTICITY IN PALLIDO-NIGRAL PROJECTION ON ROTENONE MODEL OF PARKINSON'S DISEASE UNDER ACTION OF VENOM NOX.

5. Long term osmotic stress exposure outcomes on rat dopaminergic innervations and the associated motor behavior.

6. Review of the cytology and connections of the lateral habenula, an avatar of adaptive behaving.

7. From the axons of the SNc dopamine neurons to their dendritic processes: further clues to susceptibility in Parkinson’s disease (PD)?

8. Stress Controllability Modulates Basal Activity of Dopamine Neurons in the Substantia Nigra Compacta

9. Effect of neurotoxic lesion of pedunculopontine nucleus in nigral and striatal redox balance and motor performance in rats.

10. Delayed histopathological neuronal damage in the substantia nigra compacta (nucleus A9) after transient forebrain ischaemia

11. Neuropathology and behavioral impairments in Wistar rats with a 6-OHDA lesion in the substantia nigra compacta and exposure to a static magnetic field.

12. The mesopontine rostromedial tegmental nucleus: An integrative modulator of the reward system.

13. Tetrahydroberberine blocks ATP-sensitive potassium channels in dopamine neurons acutely-dissociated from rat substantia nigra pars compacta

14. Progressive Dopaminergic Degeneration in the Chronic MPTPp Mouse Model of Parkinson’s Disease.

15. Cholinergic modulation of midbrain dopaminergic systems

16. Organization of histamine-immunoreactive, tuberomammillary neurons projecting to the dorsal tier of the substantia nigra compacta in the rat

17. Neuroprotective effect of the systemic delivery of (-) nicotine in hemiparkinsonian rats.

18. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.

19. Iptakalim inhibits nicotinic acetylcholine receptor-mediated currents in dopamine neurons acutely dissociated from rat substantia nigra pars compacta

20. Stress Controllability Modulates Basal Activity of Dopamine Neurons in the Substantia Nigra Compacta.

21. CyPPA, a Positive SK3/SK2 Modulator, Reduces Activity of Dopaminergic Neurons, Inhibits Dopamine Release, and Counteracts Hyperdopaminergic Behaviors Induced by Methylphenidate1

22. Inhibition of Rho kinase mediates the neuroprotective effects of estrogen in the MPTP model of Parkinson's disease.

Catalog

Books, media, physical & digital resources